According to its website, Beijing-based China Animal Healthcare "is a leading animal drug manufacturer focusing on the manufacture, sale and distribution of compound chemical drugs (comprising powdered drugs and injection drugs) and biological drugs (comprising Mandatory Vaccines and non-Mandatory Vaccines) for poultry and livestock in the PRC."
Submitted by Jim Quinn via The Burning Platform blog,
No volume, no problem...Buy stocks with both hands and feet...
Three weeks ago when news of the dramatic gating and liquidation of Third Avenue's high yield debt focused fund first hit, we said that "now that the dreaded gates are back, investors in all other junk bond-focused hedge funds, fearing they too will be gated, will rush to pull what funds they can and submit redemption requests, in the process potentially unleashing a liquidity - and liquidation - scramble within the hedge fund community, which will first impact bonds and then, if the liquidity demands continue, equities as well."
When last we checked in on Marc Faber, the Gloom, Boom, and Doom seer was predicting that the market had reached a “tipping point”, as thanks to QE and incessant central bank interventions, there are no safe assets left.
“It's ludicrous to believe that you will create prosperity in a system by printing money,” he said. “That is economic sophism at its best.” Or at its worst.
Shortly thereafter, Faber told Bloomberg that China's economy has most assuredly "landed hard."